Investing Profile

Milad Alucozai

InvestorVCFounderAngel
Venture Partner at Entrepreneur First
boxone.xyz/life-sciencesSan Francisco, California
Photo of Milad Alucozai, Venture Partner at Entrepreneur First
Your Intro Paths to Milad Alucozai

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Milad is a member of
NewCo Network
1599 CONNECTIONS
Harvard University Network
598 CONNECTIONS
Harvard University Network
598 CONNECTIONS
Accenture Network
268 CONNECTIONS
Stealth Company (Jean-Michel Autelli) Network
119 CONNECTIONS

Find Milad Alucozai on

cb
Current Investing Position
Entrepreneur First Venture Partner
Investment Range
$100K - $1M
Sweet Spot
$300K
Investments On Record
53
Current Fund Size
$115M

Milad Alucozai is on these Sector & Stage Rankings

Milad Alucozai's Investments On Record (43)

CompanyStageDateRound SizeTotal Raised
Replit
Series CJul 2025$250M
$870M
Co-investors: Andrew Chen (Andreessen Horowitz), Marc Andreessen (Andreessen Horowitz), Matthew Caspari (Alumni Ventures ), David Sacks (Craft Ventures), Sahin Boydas (Angel investor), Sallie Jian (SAP.iO), Naval Ravikant (Sm4rt Predictive Systems), Kevin Gabura (Carrick Capital Partners), Sathvik Bilakanti (VitalTrack Health), Matt Mazzeo (Coatue Management), Qiang "Larry" Li (AMINO Capital), Huican Zhu (AMINO Capital), Shaquille O'Neal, Paul Graham, Vinay Hiremath, Jared Leto, Joshua Webster, Mattia Astori, Sue Xu, Madhu Chamarty
Axonis Therapeutics
Series AOct 2024$120M
SeedJul 2021$5M
$120M
Co-investors: Jonathan Leff (Sofinnova Investments), Rebecca Allan (BoxOne Ventures)
Pathway Medical
SeedNov 2023$5M
$5M
Revalia Bio
Pre SeedMar 2023$5M
$20M
Co-investors: Ben Yu (Sierra Ventures), Brian Wilcove (America's Frontier Fund)
Future Fields
Series AFeb 2023$11M
$13M
Co-investors: Kira Noodleman (BEE Partners), Jim Adler (Toyota Ventures), Dave Messina (Pioneer Fund)
Eigen Therapeutics
SeedDec 2022$7M
$7M
Co-investors: Ludwig Schulze (Alumni Ventures ), Josh Kopelman (First Round Capital), Supachai Kid Parchariyanon (HOF Capital), Matthew De Silva (Builders VC), Varsha Rao (Nurx), Kevin Mahaffey (Lookout), Jano Búza (ZAKA Ventures), Supachai Kid Parchariyanon (SeaX Ventures)
Wayfinder Biosciences
SeedOct 2022$4M
$4.8M
Co-investors: Po Bronson (SOSV), Nicholas Chirls (Notation Capital)
Seqera
Series AOct 2022$21M
SeedSep 2021$6M
Pre SeedMar 2019$110K
$27M
Co-investors: Kirill Tasilov (Talis Capital), Jason Schneider (Addition), Dominik Tobschall (backtrace capital), Manuel Grossmann (Amino Collective)

most interested in

I actively invest in early-stage biology, healthcare, and deep tech companies

Milad Alucozai's Experience

Executive Expert & Mentor Harvard University2020 - Present
External Advisor AstraZeneca2020 - Present
Venture Partner Entrepreneur First2020 - Present
Mentor Creative Destruction Lab2019 - Present
Chief Business Officer Mekonos2018 - Present
Investor & Strategic Business Advisor bit.bioPresent
Inducted Member C100Present
Advisory Committee Wyss Institute at Harvard UniversityPresent
Business Development (acquired by Valo Health) Stealth Company (Jean-Michel Autelli)Present
Early Investor & Chief Business Officer Mekonos Inc.Present
Business Development Advisor (NASDAQ: ABSI) AbsciPresent
Advisory Board Member (acquired by Fountain Life) LifeOmicPresent
Head of Life Sciences & Deep Tech BoxOne VenturesPresent
Board Member Talus BioPresent
External Advisor AmgenPresent
Assistant Scientist Purdue UniversityPresent
Assistant Scientist at Birck Nanotechnology Center Discovery Park at Purdue UniversityPresent
Founding Team - Business Development (acquired by OnBoard) CellafloraPresent
Scientist at Interfacial Multiphysics Lab Discovery Park at Purdue UniversityPresent
Co-founder & Chief Operating Officer Symmetry Therapeutics, Inc.Present
Business Development (acquired by Valo Health) NewCoPresent
Board Member Mekonos Inc.Present
Executive Expert & Mentor at Harvard Innovation Labs Harvard UniversityPresent
First investor and Board Member SeqeraPresent
Co-Founder & Board Member Revalia BioPresent
Expert in Residence Digitalis CommonsPresent
Member C100Present
Co-Founder & Co-Host Code to Cure Series Wyss Institute at Harvard UniversityPresent
Co-Founder & General Partner Pamir VenturesPresent
Mentor - Recipient of Mentor of the Year Award Creative Destruction LabPresent
Member The C100Present
Assistant Scientist Purdue University Translational Neuroscience LabPresent
Business Development / Advisor (acquired by Valo Health) Numerate, Inc.Present
Visiting Scholar in Healthcare Engineering at the Regenstrief Center Purdue UniversityPresent
Business Development Advisor AbsciPresent
Strategic Business Advisor bit.bioPresent
Advisory Board Member LifeOmicPresent
Mentor (winner of Mentor of the Year Award) Creative Destruction LabPresent
Chief Business Officer Mekonos Inc.Present
Board Member Seqera LabsPresent
Visiting Scholar Wyss Institute at Harvard UniversityPresent
Strategic Expert in Residence Digitalis CommonsPresent
Tech Analyst Emerging Innovations Venture Fund Discovery Park at Purdue UniversityPresent
Chief Business Officer Corstem2018 - 2020
Business Advisor Numerate2018 - 2020
Global Portfolio & Delivery Lead Accenture2016 - 2018
Various Research Roles Purdue University2006 - 2015

Milad Alucozai's Education

Harvard University Visiting Fellow/Scholar Wyss Institute for Biologically Inspired Engineering
Maynooth University Master of Science - MS Immunology
Purdue University Bachelor of Science (B.S.) Neuroscience - University Honors Program
Purdue University RCHE/Bindley Entrepreneurship Fellow Healthcare Engineering
Maynooth University Master of Public Health (MPH) Global and Public Health
Indiana University Richard M. Fairbanks School of Public Health Doctorate Public Health
Harvard University Visiting Scholar Wyss Institute for Biologically Inspired Engineering
Purdue University Bachelors of Science Neuroscience & Biomedical Engineering